A. Lloyd

E. Cvejic, U. Vollmer-Conna, A. Lloyd, 2019, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

Cognitive deficits in patients suffering from chronic fatigue syndrome, acute infective illness or depression

I. Hickie, D. Wakefield, U. Vollmer-Conna, 1997, British Journal of Psychiatry.

Chronic fatigue and chronic fatigue syndrome: shifting boundaries and attributions.

A. Lloyd, 1998, The American journal of medicine.

Expression of matrix metalloproteinases by human plasma cells and B lymphocytes

D. Wakefield, N. Di Girolamo, A. Lloyd, 1998, European journal of immunology.

Physical and mental fatigue across the menstrual cycle in women with and without generalised anxiety disorder

Sophie H. Li, A. Lloyd, B. Graham, 2019, Hormones and Behavior.

I. Hickie, M. Friedlander, D. Goldstein, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of cytokines in the pathogenesis of inflammatory eye disease.

D. Wakefield, A. Lloyd, 1992, Cytokine.

Immunological and psychological dysfunction in patients receiving immunotherapy for chronic fatigue syndrome.

I. Hickie, D. Wakefield, A. Lloyd, 1992 .

Cell‐mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression

I. Hickie, D. Wakefield, J. Dwyer, 1992, Clinical and experimental immunology.

Predictors of Chronic Fatigue Syndrome and Mood Disturbance After Acute Infection

I. Hickie, E. Cvejic, A. Lloyd, 2022, Frontiers in Neurology.

Chronic fatigue syndrome: progress and possibilities

A. Lloyd, C. Sandler, Carolina X. Sandler, 2020, The Medical journal of Australia.

Fatigue after infection: aetiology and pathophysiology

A. Lloyd, 2013 .

Chronic Fatigue and Postinfective Fatigue Syndromes

I. Hickie, D. Wakefield, A. Lloyd, 2009 .

Chronic Fatigue Syndrome: An Immunological Perspective

D. Wakefield, U. Vollmer-Conna, A. Lloyd, 1998, The Australian and New Zealand journal of psychiatry.

Chronic fatigue syndrome: current perspectives on evaluation and management

I. Hickie, D. Wakefield, A. Lloyd, 1995, The Medical journal of Australia.

Cytokine production and fatigue in patients with chronic fatigue syndrome and healthy control subjects in response to exercise.

S. Gandevia, D. Wakefield, J. Hales, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunological abnormalities in the chronic fatigue syndrome

I. Hickie, D. Wakefield, A. Lloyd, 1990, The Medical journal of Australia.

Balance of Pro- and Anti-Inflammatory Cytokines Correlates with Outcome of Acute Experimental Pseudomonas aeruginosa Keratitis

D. Wakefield, F. Stapleton, A. Lloyd, 2002, Infection and Immunity.

Keratitis aeruginosa Pseudomonas Acute Experimental Cytokines Correlates with Outcome of Balance of Pro-and Anti-Inflammatory

D. Wakefield, F. Stapleton, A. Lloyd, 2002 .

The international collaborative on fatigue following infection (COFFI)

U. Vollmer-Conna, D. Buchwald, R. Moss‐Morris, 2018, Fatigue : biomedicine, health & behavior.

Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells.

D. Wakefield, P. McCluskey, M. Coroneo, 2000, Investigative ophthalmology & visual science.

Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.

D. Wakefield, M. Filipič, P. McCluskey, 1997, The American journal of pathology.

The temporal stability and co-morbidity of prolonged fatigue: a longitudinal study in primary care

I. Hickie, D. Hadzi-Pavlovic, A. Lloyd, 1999, Psychological Medicine.

Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta.

D. Wakefield, N. Di Girolamo, A. Lloyd, 1998, Journal of immunology.

Are cytokines associated with neuropsychiatric syndromes in humans?

I. Hickie, A. Lloyd, 1995, International journal of immunopharmacology.

Does genotype mask the relationship between psychological factors and immune function?

I. Hickie, U. Vollmer-Conna, A. Lloyd, 2005, Brain, Behavior, and Immunity.

The effectiveness of activity pacing interventions for people with chronic fatigue syndrome: a systematic review and meta-analysis

B. Barry, J. Cassar, A. Lloyd, 2022, Disability and rehabilitation.

Influences of Distress and Alcohol Consumption on the Development of a Delayed-Type Hypersensitivity Skin Test Response

I. Hickie, U. Vollmer-Conna, A. Lloyd, 2004, Psychosomatic medicine.

Biochemical correlates of in vivo cell-mediated immune dysfunction in patients with depression: a preliminary report.

I. Hickie, D. Wakefield, D. Silove, 1995, International journal of immunopharmacology.

Chronic fatigue syndrome: current concepts of pathogenesis and treatment.

I. Hickie, P. Peterson, A. Lloyd, 1999, Current clinical topics in infectious diseases.

Immunity and the pathophysiology of chronic fatigue syndrome.

I. Hickie, D. Wakefield, A. Lloyd, 1993, Ciba Foundation symposium.

Chemokine expression and leucocyte infiltration in Sjögren's syndrome.

D. Wakefield, P. McCluskey, N. Di Girolamo, 1998, British journal of rheumatology.

Acquired immunodeficiency syndrome (AIDS) and sulfadiazine-associated acute renal failure.

D. Wakefield, P. Goadsby, A. Lloyd, 1987, Annals of internal medicine.

A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome.

I. Hickie, D. Wakefield, J. M. Wright, 2000, The Journal of clinical psychiatry.

Abundant expression of chemokines in malignant and infective human lymphadenopathies.

D. Wakefield, A. Lloyd, N. Tedla, 1999, Cytokine.

The long wait for a breakthrough in chronic fatigue syndrome

J. Meer, A. Lloyd, 2015, BMJ : British Medical Journal.

Role and regulation of CXC-chemokines in acute experimental keratitis.

D. Wakefield, A. Lloyd, M. Willcox, 2003, Experimental eye research.

Reply to A. Giacalone et al

D. Goldstein, K. Webber, A. Lloyd, 2012 .

Stromelysin (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase (TIMP-1) mRNA expression in scleritis.

D. Wakefield, P. McCluskey, A. Lloyd, 1995, Ocular immunology and inflammation.

Delayed-type hypersensitivity skin testing: normal values in the Australian population.

I. Hickie, D. Wakefield, A. Lloyd, 1995, International journal of immunopharmacology.

Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis

A. Guastella, I. Hickie, D. Quintana, 2014, Molecular Psychiatry.

Cytokine polymorphisms have a synergistic effect on severity of the acute sickness response to infection.

I. Hickie, D. Wakefield, U. Vollmer-Conna, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Psychiatric Status of Patients with the Chronic Fatigue Syndrome

I. Hickie, G. Parker, D. Wakefield, 1990, British Journal of Psychiatry.

Comment on “Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome”

S. Wessely, D. Buchwald, M. Sharpe, 2010, Science.

Long COVID and Post-infective Fatigue Syndrome: A Review

Boris Katz, H. Knoop, D. Buchwald, 2021, Open forum infectious diseases.

The severity of the pathogen-induced acute sickness response is affected by polymorphisms in genes of the NLRP3 inflammasome pathway

I. Hickie, E. Cvejic, D. Wakefield, 2021, Brain, Behavior, and Immunity.

Are Chronic Fatigue and Chronic Fatigue Syndrome Valid Clinical Entities Across Countries and Health-Care Settings?

I. Hickie, W. Reeves, D. Hadzi-Pavlovic, 2009, The Australian and New Zealand journal of psychiatry.

Health-Care Settings ? Are Chronic Fatigue and Chronic Fatigue Syndrome Valid Clinical Entities Across Countries and

I. Hickie, S. Vernon, R. Nisenbaum, 2008 .

Gene expression correlates of postinfective fatigue syndrome after infectious mononucleosis.

W. Dunsmuir, I. Hickie, W. Reeves, 2007, The Journal of infectious diseases.

The treatment of chronic fatigue syndrome: science and speculation.

I. Hickie, D. Wakefield, A. Lloyd, 1994, The American journal of medicine.

What is Chronic Fatigue Syndrome? Heterogeneity Within an International Multicentre Study

I. Hickie, T. Blakely, G. Parker, 2001, The Australian and New Zealand journal of psychiatry.

RED BLOOD CELL MORPHOLOGY IN CHRONIC FATIGUE SYNDROME

D. Wakefield, J. Isbister, A. Lloyd, 1989, The Lancet.

The role of cytokines and chemokines in uveitis.

D. Wakefield, N. Di Girolamo, A. Lloyd, 1999, Developments in ophthalmology.

A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome.

I. Hickie, D. Wakefield, J. Dwyer, 1990, The American journal of medicine.

Utilising Molecular Biological and Histopathological Techniques to Study the Dopaminergic System in Patients with Melancholia

I. Hickie, D. Wakefield, G. Halliday, 1997, The Australian and New Zealand journal of psychiatry.

The natural history of acute Q fever: a prospective Australian cohort.

I. Hickie, D. Wakefield, U. Vollmer-Conna, 2016, QJM : monthly journal of the Association of Physicians.

Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial.

I. Hickie, D. Wakefield, J. Dwyer, 1993, The American journal of medicine.

WHAT IS MYALGIC ENCEPHALOMYELITIS?

D. Wakefield, J. Dwyer, A. Lloyd, 1988, The Lancet.

Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial.

P. Craft, P. de Souza, E. Hovey, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Endotoxin-induced uveitis is partially inhibited by anti-IL-8 antibody treatment.

D. Wakefield, U. Vollmer-Conna, K. Matsushima, 1999, Investigative ophthalmology & visual science.

The relationship between distress and the development of a primary immune response to a novel antigen

I. Hickie, D. Wakefield, U. Vollmer-Conna, 2004, Brain, Behavior, and Immunity.

Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder

D. Wakefield, P. Ward, S. Catts, 1996, Psychiatry Research.

Immunological abnormalities in the chronic fatigue syndrome (for editorial comment, see page 117)

D. Wakefield, J. Dwyer, A. Lloyd, 1989 .

Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome.

I. Hickie, D. Wakefield, U. Vollmer-Conna, 1997, The American journal of medicine.

Cognitive remediation training improves performance in patients with chronic fatigue syndrome

E. Cvejic, U. Vollmer-Conna, J. Cassar, 2017, Psychiatry Research.

Polymorphisms in Toll-like receptors-2 and -4 are not associated with disease manifestations in acute Q fever

I. Hickie, W. Reeves, D. Wakefield, 2007, Genes and Immunity.

Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution

Rosane Nisenbaum, Suzanne D Vernon, Peter D White, 2003, BMC health services research.

Can the chronic fatigue syndrome be defined by distinct clinical features?

I. Hickie, D. Wakefield, D. Hadzi-Pavlovic, 1995, Psychological medicine.

Prevalence of chronic fatigue syndrome in an Australian population

Ian Hickie, I. Hickie, D. Wakefield, 1990, The Medical journal of Australia.

A Twin Study of the Etiology of Prolonged Fatigue and Immune Activation

I. Hickie, N. Martin, K. Kirk, 2001, Twin Research.

Is there immune dysfunction in depressive disorders?

I. Hickie, D. Wakefield, A. Lloyd, 1990, Psychological Medicine.

Subjective sleep quality and characteristics across the menstrual cycle in women with and without Generalized Anxiety Disorder.

Sophie H. Li, A. Lloyd, B. Graham, 2021, Journal of psychosomatic research.

The Invisible Burden of Chronic Fatigue in the Community: a Narrative Review

E. Cvejic, U. Vollmer-Conna, A. Lloyd, 2019, Current Rheumatology Reports.

Reduced heart rate variability predicts poor sleep quality in a case–control study of chronic fatigue syndrome

U. Vollmer-Conna, A. Lloyd, A. Burton, 2010, Experimental Brain Research.

Fatigue Exacerbation by Interval or Continuous Exercise in Chronic Fatigue Syndrome.

B. Barry, A. Lloyd, C. Sandler, 2016, Medicine and science in sports and exercise.

E. Hovey, A. Lloyd, P. Parente, 2017, Supportive Care in Cancer.

The impact of childhood trauma on psychosocial functioning and physical health in a non-clinical community sample of young adults

E. Cvejic, U. Vollmer-Conna, A. Lloyd, 2020, The Australian and New Zealand journal of psychiatry.

Personalised relaxation practice to improve sleep and functioning in patients with chronic fatigue syndrome and depression: study protocol for a randomised controlled trial

E. Cvejic, G. Parker, U. Vollmer-Conna, 2018, Trials.

Autonomic nervous system function, activity patterns, and sleep after physical or cognitive challenge in people with chronic fatigue syndrome.

E. Cvejic, U. Vollmer-Conna, B. Barry, 2017, Journal of psychosomatic research.

Reliability revisited: autonomic responses in the context of everyday well-being.

E. Cvejic, U. Vollmer-Conna, D. Hadzi-Pavlovic, 2013, International journal of cardiology.

Reduced Cardiac Vagal Modulation Impacts on Cognitive Performance in Chronic Fatigue Syndrome

Jim Lemon, U. Vollmer-Conna, A. Lloyd, 2012, PloS one.

Longitudinal study of outcome of chronic fatigue syndrome

I. Hickie, D. Wakefield, D. Hadzi-Pavlovic, 1994, BMJ.

If I am in the mood, I enjoy it: an exploration of cancer-related fatigue and sexual functioning in women with breast cancer.

M. Friedlander, D. Goldstein, K. Webber, 2011, The oncologist.

Regulation of the acute sickness response by the P2X7 receptor.

I. Hickie, E. Cvejic, D. Wakefield, 2021, The Journal of infectious diseases.

Mood disturbance after infection

U. Vollmer-Conna, A. Lloyd, P. Gunaratne, 2013, The Australian and New Zealand journal of psychiatry.

Autonomic hyper-vigilance in post-infective fatigue syndrome

U. Vollmer-Conna, U. Schall, Gavin Cooper, 2010, Biological Psychology.

Neurocognitive disturbances associated with acute infectious mononucleosis, Ross River fever and Q fever: A preliminary investigation of inflammatory and genetic correlates

I. Hickie, E. Cvejic, U. Vollmer-Conna, 2014, Brain, Behavior, and Immunity.

Screening for prolonged fatigue syndromes: validation of the SOFA scale

I. Hickie, D. Wakefield, D. Hadzi-Pavlovic, 2000, Social Psychiatry and Psychiatric Epidemiology.

Randomized Evaluation of Cognitive-Behavioral Therapy and Graded Exercise Therapy for Post-Cancer Fatigue.

M. Friedlander, B. Barry, D. Goldstein, 2017, Journal of pain and symptom management.

Impaired In Vivo Immune Responses in Patients with Melancholia

I. Hickie, D. Wakefield, D. Silove, 1993, British Journal of Psychiatry.

Parasympathetic activity is reduced during slow-wave sleep, but not resting wakefulness, in patients with chronic fatigue syndrome.

E. Cvejic, U. Vollmer-Conna, A. Lloyd, 2020, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

Sleep-wake behavior in chronic fatigue syndrome.

Alexander Burton, Sally Galbraith, Ute Vollmer-Conna, 2011, Sleep.

Self-reported health, lifestyle and social circumstances of Australian adult cancer survivors: A propensity score weighted cross-sectional study.

D. Goldstein, K. Webber, M. Harris, 2020, Cancer epidemiology.

Fatigue: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

G. Bleijenberg, D. Buchwald, N. Klimas, 2007, Vaccine.

CCR5 Expression Correlates with Susceptibility of Maturing Monocytes to Human Immunodeficiency Virus Type 1 Infection

Hassan Mohammad Naif, A. Sloane, L. Wu, 1998, Journal of Virology.

Increased matrix metalloproteinases in the aqueous humor of patients and experimental animals with uveitis.

D. Wakefield, P. McCluskey, N. Di Girolamo, 1996, Current eye research.

Predictors of resilience in women treated for breast cancer: A prospective study

M. Friedlander, D. Goldstein, K. Webber, 2012 .

Chemokines and T lymphocyte recruitment to lymph nodes in HIV infection.

D. Wakefield, J. Dwyer, A. Lloyd, 1996, The American journal of pathology.

Peripheral blood gene expression in postinfective fatigue syndrome following from three different triggering infections.

U. Vollmer-Conna, S. Galbraith, A. Lloyd, 2011, The Journal of infectious diseases.

Immunological and Psychological Dysfunction in Patients Receiving Immunotherapy for Chronic Fatigue Syndrome

D. Wakefield, A. Lloyd, I. Hickie, 1992, The Australian and New Zealand journal of psychiatry.

The response of patients with chronic fatigue syndrome to intravenously administered gammaglobulin

I. Hickie, D. Wakefield, J. Dwyer, 1991 .

IN CHRONIC FATIGUE SYNDROME Sleep-Wake Behavior in Chronic Fatigue Syndrome

U. Vollmer-Conna, S. Galbraith, A. Lloyd, 2011 .

SLEEP-WAKE BEHAVIOR IN CHRONIC FATIGUE SYNDROME Sleep-Wake Behavior in Chronic Fatigue Syndrome

U. Vollmer-Conna, S. Galbraith, A. Lloyd, 2011 .

Characterization of Fatigue States in Medicine and Psychiatry by Structured Interview

I. Hickie, U. Vollmer-Conna, D. Goldstein, 2014, Psychosomatic medicine.

Serum cytokine levels in postinfective fatigue syndrome.

A. Lloyd, B. Cameron, D. Ablashi, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cell-mediated immune function and the outcome of chronic fatigue syndrome.

I. Hickie, D. Wakefield, D. Hadzi-Pavlovic, 1995, International journal of immunopharmacology.

Fatigue in selected primary care settings: sociodemographic and psychiatric correlates

I. Hickie, D. Hadzi-Pavlovic, A. Lloyd, 1996, The Medical journal of Australia.

Randomised controlled trial of online continuing education for health professionals to improve the management of chronic fatigue syndrome: a study protocol

B. Barry, J. Cassar, A. Lloyd, 2020 .

A randomised controlled trial of online continuing education for health professionals to improve the management of chronic fatigue syndrome. A study protocol

B. Barry, J. Cassar, Sophie H. Li, 2017 .

Muscle strength, endurance and recovery in the post-infection fatigue syndrome.

S. Gandevia, A. Lloyd, J. Hales, 1988, Journal of neurology, neurosurgery, and psychiatry.

Anomalies in the review process and interpretation of the evidence in the NICE guideline for chronic fatigue syndrome and myalgic encephalomyelitis

S. Flottorp, P. Henningsen, I. Nazareth, 2023, Journal of Neurology, Neurosurgery, and Psychiatry.

Capturing the post-exertional exacerbation of fatigue following physical and cognitive challenge in patients with chronic fatigue syndrome.

E. Cvejic, U. Vollmer-Conna, B. Barry, 2015, Journal of psychosomatic research.

To exercise or not to exercise in chronic fatigue syndrome? No longer a question

A. Lloyd, 2004, The Medical journal of Australia.

Muscle performance, voluntary activation, twitch properties and perceived effort in normal subjects and patients with the chronic fatigue syndrome.

S C Gandevia, S. Gandevia, A. Lloyd, 1991, Brain : a journal of neurology.

Genetic associations of fatigue and other symptom domains of the acute sickness response to infection

U. Vollmer-Conna, A. Lloyd, A. Lloyd, 2011, Brain, Behavior, and Immunity.

Randomised controlled trial of online continuing education for health professionals to improve the management of chronic fatigue syndrome: a study protocol

B. Barry, J. Cassar, Sophie H. Li, 2017 .

Prolonged Fatigue, Anxiety and Depression: Exploring Relationships in a Primary Care Sample

I. Hickie, D. Hadzi-Pavlovic, A. Lloyd, 1999, The Australian and New Zealand journal of psychiatry.

Immune response genes in the post-Q-fever fatigue syndrome, Q fever endocarditis and uncomplicated acute primary Q fever.

A. Lloyd, H. Dunckley, R. Harris, 2005, QJM : monthly journal of the Association of Physicians.

Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy

P. Craft, P. de Souza, E. Hovey, 2014, Supportive Care in Cancer.

Autonomic hyper-vigilance in post-infective fatigue syndrome

U. Vollmer-Conna, U. Schall, Gavin Cooper, 2010, Biological Psychology.

Cytokine polymorphisms have a synergistic effect on severity of the acute sickness response to infection.

I. Hickie, D. Wakefield, U. Vollmer-Conna, 2008, Clinical Infectious Diseases.

Neurocognitive disturbances associated with acute infectious mononucleosis, Ross River fever and Q fever: A preliminary investigation of inflammatory and genetic correlates

I. Hickie, E. Cvejic, U. Vollmer-Conna, 2014, Brain, Behavior, and Immunity.

Neuropsychiatric symptoms and immune activation in patients with genital herpes

U. Vollmer-Conna, A. Lloyd, B. Donovan, 2008, Acta Neuropsychiatrica.